Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Yael L. Maxwell

December 12, 2022

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

L.A. McKeown

November 04, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

News Daily News

HF Deaths on the Rise in Young Adults, US Data Show

L.A. McKeown

August 03, 2022

News Daily News

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

Yael L. Maxwell

July 22, 2022

News Daily News

Social Factors Contribute to Race Differences in Premature CVD: CARDIA

Yael L. Maxwell

May 30, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

The NCDR Has Made a Difference, but Experts See Room for Growth

Todd Neale

April 28, 2022

News Daily News

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

L.A. McKeown

March 01, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes

Michael O'Riordan

February 16, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Advertisement

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

HF Deaths on the Rise in Young Adults, US Data Show

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

Social Factors Contribute to Race Differences in Premature CVD: CARDIA

Good News and Bad for High-Intensity Statin Use in ASCVD

The NCDR Has Made a Difference, but Experts See Room for Growth

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Complete Anesthesia Handover in Cardiac Surgery Leads to Worse Outcomes

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content